Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jul 28, 2009; 15(28): 3504-3510
Published online Jul 28, 2009. doi: 10.3748/wjg.15.3504
Published online Jul 28, 2009. doi: 10.3748/wjg.15.3504
Table 4 Summary of Cox regression model: factors affecting time to disease behavior change
P-value | Hazard ratio | 95% CI | |
Disease location | 0.001 | ||
L1 | 0.023 | 2.13 | 1.11-4.08 |
L2 | 0.05 | 0.54 | 0.27-1.001 |
L3 | Reference | ||
Perianal disease | |||
Yes | < 0.001 | 3.26 | 1.90-5.59 |
No | Reference | ||
Steroid use | |||
Yes | 0.006 | 7.48 | 1.79-31.2 |
No | Reference | ||
Early azathioprine use | |||
Yes | 0.005 | 0.46 | 0.27-0.79 |
No | Reference | ||
Smoking status | |||
Yes | 0.032 | 1.79 | 1.05-3.05 |
No | Reference |
- Citation: Lakatos PL, Czegledi Z, Szamosi T, Banai J, David G, Zsigmond F, Pandur T, Erdelyi Z, Gemela O, Papp J, Lakatos L. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn’s disease. World J Gastroenterol 2009; 15(28): 3504-3510
- URL: https://www.wjgnet.com/1007-9327/full/v15/i28/3504.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3504